Abiopharma

🔍 Shiferman Gregory L. (Executive)

Company: Voyager Therapeutics, Inc. (VYGR)

Report Date: 2026-01-06

Detailed Transactions and Holdings:

• Acquired 100,000 shares of Stock Option (Right to Buy) at $4.02 per share (Derivative)
  Date: 2026-01-06 | Code: A | Expires: 2036-01-06 | equity_swap_involved: 0 | shares_owned_after: 100,000.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: This stock option was granted pursuant to the Voyager Therapeutics, Inc. 2025 Stock Incentive Plan.
• F2: The vesting commencement date of the option is the grant date. The option vests over four years, with 1/4th of the shares of common stock underlying the option vesting upon the one-year anniversary of such vesting commencement date and an additional 1/48th of the shares of common stock underlying the option vesting at the end of each successive one-month period thereafter, subject to the Reporting Person's continued service as an employee.